DecreaseText Size Reset Text Size Increase Text Size
 
resize Print E-mail
Search
News
31/08/2015
Manufacturing

Today, our company's plant is considered as the one of the few pharmaceutical manufacturing sites in Europe with fully integrated production lines, including dedicated lines for Transdermal delivery systems.

Our production facilities are designed and built to operate under strict, controlled, regulated and recorded conditions of Temperature (T), humidity (RH%), and air clearance according to international standards.

Our advanced and fully automated production facilities cover an area of 8,000 m2 dedicated mostly to the production lines for transdermal systems and packaging. The whole chain of a product’s manufacturing -from the feedstock to its final packaging- is controlled by the automated production equipment, meeting quality and international standards. Having installed a monitoring and control mechanism system of production lots, we are  in position to recall -if needed- at any moment any product, which can cause adverse reactions to a patient, ensuring thus public health.

Our company, following the European and U.S.A. Good Manufacturing Practices (GMPs) and Good Distribution Practices (GDPs), has established independent Departments of Quality Assurance (QA) and Quality Control (QC) under a complete Quality System.


Annual Production Capacity
Pharmaceutical Products
Tablets 830 million tablets
Capsules 47 million capsules
Transdermal Delivery Systems 140 million
Liquid 23 million bottles
Creams & Ointment 8 million tubes

Cosmetics
Creams and Emulsions              4,5 million tubes
Shampoos and Lotions             6 million bottles

For more information please contact: manufacturing@lavipharm.com 

 





Copyright© 2011 Lavipharm. All Rights Reserved | Legal Restrictions & Terms of use | Privacy Policy